Literature DB >> 9431588

Chronic massive knee effusion in familial Mediterranean fever.

M Salai1, D Zemmer, E Segal, A Corat, Z Heyman, B Davidson, P Langevitz, A Livneh.   

Abstract

OBJECTIVE: To document the occurrence of chronic massive knee effusions in patients with familial Mediterranean fever (FMF). PATIENTS: Three cases of chronic massive knee effusion of young FMF patients requiring open synovectomy are presented.
RESULTS: Open synovectomy necessitated protracted rehabilitation, eventually with good results.
CONCLUSIONS: FMF should be considered in the differential diagnosis of chronic massive knee effusion. Early diagnosis and daily colchicine treatment generally result in a good clinical outcome and may eliminate the need for open synovectomy in favor of arthroscopic surgery.

Entities:  

Mesh:

Year:  1997        PMID: 9431588     DOI: 10.1016/s0049-0172(97)80016-9

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  4 in total

1.  Familial Mediterranean fever mimicking septic arthritis.

Authors:  Imad Uthman; Jinane El-Sayyad; Ihab El-hajj; Abdul-Rahman Bizri
Journal:  Rheumatol Int       Date:  2005-02-08       Impact factor: 2.631

2.  Sulphasalazine treatment in protracted familial Mediterranean fever arthritis.

Authors:  Sevcan A Bakkaloglu; Tekin Aksu; Berna Goker; Aysel Unlusoy; Harun Peru; Kibriya Fidan; Oguz Soylemezoglu; Enver Hasanoglu; Necla Buyan
Journal:  Eur J Pediatr       Date:  2008-11-26       Impact factor: 3.183

Review 3.  A novel treatment of temporomandibular joint arthritis as a complication in familial Mediterranean fever-literature review and a case report.

Authors:  Boaz Frenkel; Tal Berg; Amir Totry; Adi Rachmiel
Journal:  Oral Maxillofac Surg       Date:  2018-10-19

Review 4.  The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease.

Authors:  Eitan Giat; Ilan Ben-Zvi; Merav Lidar; Avi Livneh
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.